AI Science Tracker
EN

Construction of a radiogenomics predictive model for KRAS mutation status in patients with non-small cell lung cancer.

The Affiliated Hospital of Southwest Medical University · 26 Jun 2025 · medicine

Discovery

Construction of a radiogenomics predictive model for KRAS mutation status in patients with non-small cell lung cancer.

Source check: Source checked. Not independent scientific confirmation.

Finding: A differential-evolution-optimized ANN integrated PET/CT radiomics and genomic features to predict KRAS mutation status in NSCLC; internal bootstrap AUC 0.909 versus conventional ANN 0.819. Public retrospective datasets only. Testing: A differential-evolution-optimized ANN integrated PET/CT radiomics and genomic features to predict KRAS mutation status in NSCLC; internal bootstrap AUC 0.909 versus conventional ANN 0.819. Public retrospective datasets only.. Source affiliation was not stated in the reviewed case checks and was unavailable in the local bibliographic cache.

Technology: A differential-evolution-optimized ANN integrated PET/CT radiomics and genomic features to predict KRAS mutation status in NSCLC; internal bootstrap AUC 0.909 versus conventional ANN 0.819. Public retrospective datasets only.

Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

AI contribution
A differential-evolution-optimized ANN integrated PET/CT radiomics and genomic features to predict KRAS mutation status in NSCLC; internal bootstrap AUC 0.909 versus conventional ANN 0.819. Public retrospective datasets only.
Test and result
A differential-evolution-optimized ANN integrated PET/CT radiomics and genomic features to predict KRAS mutation status in NSCLC; internal bootstrap AUC 0.909 versus conventional ANN 0.819. Public retrospective datasets only.
Limitation / still unknown
A differential-evolution-optimized ANN integrated PET/CT radiomics and genomic features to predict KRAS mutation status in NSCLC; internal bootstrap AUC 0.909 versus conventional ANN 0.819. Public retrospective datasets only.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://pmc.ncbi.nlm.nih.gov/articles/PMC12268479/ · https://europepmc.org/article/MED/40688342

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.

Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 3/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open in the full catalog for filters, charts and related discoveries. Browse medicine discoveries.